70359-46-5 Brimonidine tartrate AKSci J11238
 
 
Loading Please Wait...
  J11238    AKSci Reference Standard
Brimonidine tartrate
, >98% (HPLC), powder
 
Structure N/A

IDENTITY
CAS Number:70359-46-5
MDL Number:MFCD07773072
MF:C11H10BrN5.C4H6O6
MW:442.22
SPECIFICATIONS & PROPERTIES
Purity:>98% (HPLC), powder
Physical Form:Light yellow powder
Melting Point:213-218°C
Long-Term Storage:Store long-term at -20°C
UN #:UN2811
Hazard Class:6.1
Packing Group:III

BIOLOGICAL INFO
Solubility:Soluble in DMSO and Methanol

REVIEW

 Brimonidine is an alpha adrenergic receptor agonist (primarily alpha-2). It has a peak ocular hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and humans suggest that Brimonidine has a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow.

REFERENCES
[1]Toris, C.; Camras, C.; Yablonski, M. (1999). Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. American journal of ophthalmology 128 (1): 8-14. PMID 10482088.

GHS

Pictograms

Signal Word
Warning

Hazard Statements
H315; H319; H335

Precautionary Statements
P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501


Current as of August 21, 2019

AKSci Reference Standards are high-purity, low-impurity compounds suitable for use as standards.


Download SDS

For research use only. Not for diagnostic or therapeutic use.
Not for human use.


CATEGORIES

 APIs and Bioactives > Adrenergic Agonists


PubChem